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Long-term Intrinsic Rhythm Evaluation in Dogs with
Atrioventricular Block
R.A. Santilli, D.M. Porteiro Vazquez, T. Vezzosi, and M. Perego
Background: Atrioventricular block (AVB) is a conduction abnormality along the atrioventricular node that, depending
on etiology, may lead to different outcomes.
Objectives: To evaluate variations of intrinsic rhythm (IR) in dogs that underwent pacemaker implantation (PMI).
Animals: Medical records of 92 dogs affected by 3rd degree atrioventricular block (3AVB), advanced 2nd degree AVB
(2AVB), paroxysmal 3AVB, 2:1 2AVB, or 3AVB with atrial fibrillation (AF) were retrospectively reviewed.
Method: The patient IR was documented with telemetry on the day of 1 – (95% CI, 1–2), 33 – (95% CI, 28–35), 105 –
(95%CI, 98–156), and 275 days (95%CI, 221–380) after PMI. According to AVB grade at different examinations, AVB was
defined as progressed, regressed, or unchanged.
Results: In 48 dogs, 3AVB remained unchanged, whereas in 7 it regressed. Eight cases of 2AVB progressed, 3 regressed
and 2 remained unchanged. Eight cases of paroxysmal 3AVB progressed and 3 remained unchanged. Four dogs affected by
2:1 2AVB progressed, 2 regressed, and 1 remained unchanged. All cases with 3AVB with AF remained unchanged. Regres-
sion occurred within 30 days after PMI, whereas progression was documented at any time. Variations in IR were associated
with type of AVB (P < .03) and time of follow-up (P < .0001).
Conclusions and clinical importance: The degree of AVB assessed at the time of PMI should not be considered definitive
because more than one-third of the cases in this study either progressed or regressed. Additional studies would be necessary
to elucidate possible causes for transient AVB in dogs.
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Atrioventricular block (AVB) is a relatively commoncardiac arrhythmia that results from conduction
abnormalities along the atrioventricular node (AVN),
the His-Purkinje system, or both. Atrioventricular
blocks accounted for approximately 20% of all canine
arrhythmias in 1 large study.1
Dogs with AV nodal conduction abnormalities may
be asymptomatic or may experience severe clinical signs
such as syncope and sudden death secondary to brady-
cardia, ventricular arrhythmias, or both.2 Advanced
2nd degree AVB (2AVB) and 3rd degree AVB (3AVB)
are reported in the literature as the most common indi-
cations for permanent pacemaker implantation (PMI)
in dogs.2
Chronic fibrous or fibrous-fatty replacement of
the AV bundle and branches, and acute lymphocytic–
plasmacytic myocarditis are reported as causes for AVB
in dogs.3–6 Chronic and progressive AVB has been
reported in older dogs and is thought to be caused by
AV bundle degeneration, atrophy, and loss of conduc-
tion fibers secondary to compression and distortion of
the central fibrous body.3 This condition is similar to
Lev’s disease in humans, in which degeneration of the
AV conduction system leads to progressive and
persistent AVB.7 Conversely, a transient form of AVB,
characterized by an acute onset and high resolution
rate, has been reported in children affected by acute
lymphocytic myocarditis.8–10 This type of AVB also has
been described in young dogs,4–6 and is characterized by
severe lymphocytic–plasmacytic myocarditis and mild
fibrous-fatty replacement involving the AV node.4–6
Other uncommon causes of AVB reported in dogs
include infectious diseases (Borrelia burgdorferi, Bar-
tonella vinsonii),11,12 bacterial endocarditis,13,14 parasitic
diseases (Trichinella spiralis),15 immune-mediated dis-
eases (myasthenia gravis, lupus erythematosus),16,17 neo-
plasia,18–20 and non-penetrating chest trauma.21,22
Because in human patients, different causes of AVB
have been documented to lead to different outcomes,
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we hypothesized that long-term analysis of the intrinsic
rhythm (IR) in dogs after PMI would disclose similar
changes.
Materials and Methods
Medical records of 140 dogs with symptomatic AVB, which
underwent PMI at Clinica Veterinaria Malpensa between January
2006 and December 2011, were retrospectively reviewed. Dogs
with long-term follow-up (at least 6 months after PMI) were
included in the study. Breed, sex, age, weight, physical examina-
tion findings, 12-lead surface electrocardiogram (ECG), thoracic
radiographs, and standard echocardiogram were available for each
dog. AVB grade, ventricular rate, and QRS duration at the time
of PMI (T0), and AVB grade and ventricular rate at each follow-
ing telemetric re-evaluation,ab were analyzed by 1 author (RAS):
T1, 1 day after PMI (95% coefficient interval [CI], 1–2); T2,
33 days after PMI (95% CI, 28–35); T3, 105 days after PMI (95%
CI, 98–156); T4, 275 days after PMI (95% CI, 221–380). Atrioven-
tricular blocks were graded as follows: 3AVB was defined as com-
plete atrioventricular block; 2AVB was defined as second degree
AVB with atrioventricular conduction ratio ≥3:1; 2:1 2AVB was
defined as AVB with atrioventricular conduction ratio of 2:1;
paroxysmal 3AVB was defined as a sudden and transient complete
AVB.23
During telemetric ECG interrogation, pacing was set at 30 bpm
for 30 seconds and IR was defined as the underlying cardiac
rhythm recorded with a ventricular rate slower than the minimum
pacing cycle length set. In case of lack of occurrence of IR, the
dog was defined as “PM dependent”.24 The IR with a ventricular
rate faster than the minimum pacing cycle length set was analyzed
for the entire duration of the telemetric interrogation. Based on
long-term IR evaluation, we classified the dogs in 3 groups accord-
ing to the presence or absence of changes in AV conduction over
time: unchanged, progressed, and regressed. The unchanged group
included dogs in which IR did not change at any re-evaluations.
The progressed group included dogs in which worsening of AV
conduction was documented. We defined progressed as a 2:1
2AVB that became 2AVB or 2AVB that progressed to 3AVB.
Paroxysmal 3AVB was considered progressed when it became a
persistent 2:1 2AVB, 2AVB, or 3AVB. The regressed group
included dogs in which there was an improvement in AV conduc-
tion. We defined regressed as any case of 2AVB that became a 2:1
2AVB, any 3AVB that became a 2AVB, and any AVB that
regressed to sinus rhythm.
Statistical Methods
The study population consisted of 92 dogs, data on age (years),
weight (kg), sex, breed, type of AVB (3AVB, 2AVB, paroxysmal
3AVB, 2:1 2AVB, and 3AVB associated with AF), outcome (pro-
gressed, regressed, or unchanged AV conduction) were recorded.
Descriptive statistics were performed. On quantitative variables
(age, weight, heart rate, QRS duration, T1, T2, T3, T4), normal
distribution of values was assessed by the Shapiro–Wilk W-test
and mean, median and standard deviation were calculated. Cate-
gorical variables (sex, type of AVB, changes in AV conduction,
outcome) were expressed as percentage. A general linear model
(GLM) ANOVA was used to compare QRS duration among the 3
outcome groups (progressed, regressed, unchanged AV conduc-
tion) after controlling for type of AVB, age, and weight on a sub-
sample of 81 bradycardic dogs (11 dogs with paroxysmal 3AVB
were excluded from this analysis to make the data set more homo-
geneous). A chi-square test was used to test associations between
outcomes and the following variables: QRS duration (≤75 msec,
>75 msec), type of AVB, and time from PMI (T0, T1, T2, T3,
T4). Logistic regression analysis was used to investigate the associ-
ation between QRS duration and outcome, age, sex, weight, type
of AVB, and time from PMI.
All statistical analyses were carried out using commercially
available softwarec , and the level of statistical significance was set
at P < .05.
Results
The study population included 92 dogs (49 males
and 43 females) of different breeds. Mean age was
8.8  3.3 years and mean body weight was 26.5 
12.8 kg. Indications for PMI included: 3AVB (59.8%,
55/92), 2AVB (14.1%, 13/92), paroxysmal 3AVB
(12.0%, 11/92), 2:1 2AVB (7.6%, 7/92), and 3AVB
associated with AF (6.5%, 6/92).
At follow-up re-evaluations, 65.2% of dogs (60/92)
had no IR changes, 21.8% (20/92) had AVB progres-
sion, and 13% (12/92) had AVB regression. Regressed
cases, which converted to sinus rhythm, were 66.6% (8/
12).
Changes in the type of AVB are shown in Table 1. In
87.2% of the cases (48/55), 3AVB remained unchanged
during the follow-up period. In 12.7% of dogs (7/55),
the 3AVB regressed in 4 cases to sinus rhythm, in 2
cases to 2:1 2AVB, and in 1 case to 2AVB. Paroxysmal
3AVBs showed progression in 72.7% of dogs (8/11) in
5 dogs to 3AVB, in 3 dogs to 2:1 2AVB, and in 3 dogs
AVB remained unchanged. In all cases of 3AVB associ-
ated with AF, the IR remained unchanged. In dogs
with 2AVB, progression to 3AVB was observed in
61.5% of cases (8/13), whereas 15.4% (2/13) remained
unchanged. In 23.1% of the cases (3/13), 2AVB
regressed to sinus rhythm in 2 dogs and to 2:1 2AVB in
1 dog. Dogs with 2:1 2AVB progressed to 3AVB in
57.1% of the cases (4/7), whereas in 28.6% (2/7) it
regressed to sinus rhythm, and in 1 dog it remained
unchanged.
Results of GLM ANOVA showed a difference in
heart rate (HR) among types of AVB (test F 3.25
P < .03) and outcomes (test F 3.29; P < .04). The Chi-
square test showed an association between changes in
IR at different follow-up time points and type of AVB
Table 1. Changes of intrinsic rhythm and atrioventric-
ular conduction in 92 dogs underwent pacemaker
implantation for high grade atrioventricular block.
Unchanged
(n)
Progressed
(n)
Regressed
(n)
Total
(n)
2:1 2AVB 1 4 2 7
Advanced 2AVB 2 8 3 13
3AVB 48 0 7 55
3AVB + AF 6 0 0 6
Paroxysmal 3AVB 3 8 0 11
Total 60 20 12 92
% 65,2 21,7 13 100
2:1 2AVB, 2:1 second degree atrioventricular block; 2AVB, sec-
ond degree atrioventricular block; 3AVB, third degree atrioventric-
ular block; AF, atrial fibrillation.
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(P < .03). Concerning timing of variations in AV con-
duction (Table 2), no changes were observed at T1.
Progression was observed at any time point in the fol-
low-up, whereas all regressions occurred within T2
(P < .0001).
A Chi-square test showed an association between
type of AVB and outcome (P < .0001). Pacemaker
dependency was documented in 40 of 92 dogs (43.5%).
Complete AVB, either alone or associated with AF,
showed more frequently showed pacemaker (PM)
dependency, respectively 52.7% (29/55) and 50% (3/6),
whereas in the other types of AVB PM dependency was
less frequent: paroxysmal 3AVB (27.3%, 3/11), 2:1
2AVB (28.6%; 2/7), and 2AVB (23.1%, 3/13).
Discussion
Our study analyzed data from long-term follow-up
of 92 dogs with AVB that underwent PMI, and identi-
fied changes in AV nodal conduction over time. In
our population, 87% of cases showed persistent
(65.2%) or progressive (21.8%) AV conduction distur-
bance, whereas in 13% of the dogs improvement of
AV block was recorded. The majority of dogs
reported here presented with similar changes in AV
conduction disturbances over time as have been
described in human patients, where 83% of the cases
affected by AVB and treated with permanent PMI
show persistent and progressive AVB at long-term
follow-up.25–27 Progressive idiopathic fibrosis of the
conduction system related to aging of the cardiac
skeleton (Lev’s disease) is the most common cause of
chronic acquired AVB in humans.7,8 Presumably, most
of our cases of unchanged or progressive AVB suf-
fered from chronic fibrous or fibrous-fatty replacement
of the AV bundle and branches, as previously
reported in the veterinary literature.3 In our study,
paroxysmal 3AVB progressed to permanent 3AVB in
the majority of the dogs, and in all cases of 3AVB
with AF improvement in AV conduction disturbances
was not documented. On the basis on these results,
we speculate that these conditions may represent the
initial and terminal phases of chronic progressive con-
duction system degeneration.
In our study, most cases of 2:1 2AVB progressed to
3AVB in a variable period of time that ranged from 33
to 105 days. These results are not in agreement with
findings in human patients where 2:1 2AVB is consid-
ered a stable AV conduction disturbance.26 These find-
ings support the need for PMI in dogs with 2:1 2AVB,
if other causes of AVB have been ruled out.
Interestingly, 13% of dogs in our study had transient
AVB. Improvement in AV conduction is reported to
occur in approximately 15% of human patients diag-
nosed with AVB,9,25–27 whereas in veterinary medicine
only 1 study described 2 cases of transient AVB that
reverted to sinus rhythm within 6 months after PMI.28
The most common cause of transient AVB in humans is
acute myocarditis.8–10 The pathogenesis of transient
AVB secondary to acute myocarditis implies the pres-
ence of myocardial interstitial edema and a correlation
between severity of myocardial hypertrophy and grade
of AVB has been described.29 Experimental models of
acute myocarditis, as well as human patients with spon-
taneously occurring acute lymphocytic myocarditis, very
often present with AVB that occurs within a few days
or, less frequently, after 2–3 weeks, and regresses com-
pletely during the convalescent stage at 2–4 weeks in
67–96% of the patients.9,10,29–31 Similarly, in all dogs
reported here that showed regression of AVB, improve-
ment was recorded within 1 month after PMI. The
prevalence of persistent AVB after acute myocarditis is
approximately 4%,29 and in these patients permanent
PMI is required. In children, the occurrence of persis-
tent AVB secondary to resolved acute myocarditis is
higher (28%).10 Chronic myocarditis as a cause of long-
standing AVB in human beings is considered somewhat
uncommon. The presence of chronic myocarditis was
proven in 3 (6%) of 50 patients with idiopathic AVB in
1 study.32
The prevalence of myocarditis-related AVB in dogs is
unknown. In the veterinary literature, only a few case
reports have described acute myocarditis in dogs with
AVB, but solely based on postmortem examination.4–6
In 1 of these case reports, very high serum concentra-
tion of cardiac troponin I (cTnI) was documented
(44.65 ng/mL), and the authors suggested that this bio-
marker may help detect dogs with AVB secondary to
active myocarditis.4
In human medicine, endomyocardial biopsy is the
gold standard for in vivo diagnosis of myocarditis, and
increased serum concentrations of troponin I and T
are considered reliable to confirm this diagnosis
because of their high specificity but limited sensitiv-
ity.33,34 Interestingly, 1 study indicated that cTnI con-
centration was significantly higher in patients with
myocarditis and symptoms lasting ≤1 month, suggest-
ing a higher sensitivity of the test in the acute phase of
the disease.35 Cardiac troponin I concentration >99%
Table 2. Timing of variations of intrinsic rhythm and
atrioventricular conduction in 92 dogs underwent pace-
maker implantation of high grade atrioventricular
block.
T1
(CI 1–2
days)
T2
(CI 8–35
days)
T3
(CI 98–156
days)
T4
(CI 221–380
days)
2:1 2AVB 0 P 2 P 2 P 0 P
0 R 2 R 0 R 0 R
Advanced
2AVB
0 P 6 P 2 P 0 P
0 R 3 R 0 R 0 R
Paroxysmal
3AVB
0 P 4 P 3 P 1 P
0 R 0 R 0 R 0 R
3AVB 0 P 0 P 0 P 0 P
0 R 7 R 0 R 0 R
2:1 2AVB, 2:1 second degree atrioventricular block; 2AVB, sec-
ond degree atrioventricular block; 3AVB, third degree atrioventric-
ular block; P, progressed; R regressed. The chi-square test showed
an association between changes in intrinsic rhythm at different fol-
low-up time-points and the type of AVB (P < .03).
60 Santilli et al
of the normal reference range is indicative of acute
myocardial necrosis, although different extracardiac
causes for increases in serum cTnI concentration have
been reported.36–38
In veterinary medicine, cTnI serum concentration is
a sensitive and specific marker of myocardial injury
and has been used to quantify the extent of cellular
injury in dogs.38–40 A few studies showed that dogs
with AVB frequently have cTnI serum concentrations
above the reference range. This is likely secondary to
decreased cardiac output, structural remodeling sec-
ondary to volume overload, presence of congestive
heart failure, or underlying cardiomyopathy or
myocarditis.41–43 In 1 study, myocarditis was suspected
in dogs with AVB that had very high serum cTnI
concentrations and concurrent positive Bartonella spp.
serology or in dogs that developed a dilated-hypokinetic
phenotype after PMI with persistently increased cTnI
serum concentrations.41 Other possible explanations,
besides chronic myocarditis,34,44 for these cases include
cardiomyopathy with secondary AVB or pacing-induced
cardiomyopathy.45–47
In our study, PM dependency was found in 43.5% of
the cases, similar to what has been reported in the
human literature, where the time of onset is approxi-
mately 3 years.24,26,48
Limitations of this study include its retrospective nat-
ure, which influenced particularly the timing of re-eva-
luation: T1 and T2 were homogeneous whereas T3 and
T4 had wider CI. Intrinsic rhythm was evaluated during
a limited time frame, and for this reason paroxysmal
AVB could not be completely ruled out. Furthermore,
this study lacked information on QRS duration and
intraventricular conduction abnormalities at re-evalua-
tions. This parameter should have been considered
because in human beings with AV nodal conduction
disturbances, intraventricular conduction changes over
time and its assessment assists in staging progression of
AVB.25,30 Finally, serum cTnI concentrations and
endomyocardial biopsy were not performed in the dogs
reported here. These tests could have been particularly
useful in dogs with transient AV nodal conduction
abnormalities in an attempt to rule out acute myocardi-
tis in this subset of dogs.
Conclusion
Based on our results, AV nodal conduction distur-
bances remained unchanged or progressed in 87% of
dogs with AVB, suggesting the presence of a chronic
and progressive degenerative process affecting the con-
duction system (likely similar to Lev’s disease). For this
reason, PMI should be considered as the first line of
treatment not only in dogs with 2AVB and 3AVB but
also in dogs with 2:1 2AVB. Conversely, AVB
regressed within 1 month after diagnosis in 13% of
cases, 67% of which returned to sinus rhythm. Addi-
tional studies would be necessary to assess the preva-
lence of acute lymphocytic myocarditis in this subset of
dogs.
Footnotes
a Medtronic CareLink 2090: Medtronic, Minneapolis, Minnesota,
USA
b St. Jude Merlin PCS 3330: St. Jude, Saint Paul, Minnesota, USA
c SASV9.2: SAS institute inc., Cary, North Carolina, USA
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